Mohammed Mujahid Alam

The growing demand for efficient, selective, and environmentally friendly strategies to construct biologically relevant molecules has driven continuous innovation in coupling and condensation reagents. Among these, n-propylphosphonic anhydride (T3P®) has emerged as a versatile and green reagent for a wide range of bond-forming transformations. Recognized as an environmentally benign alternative to traditional agents such as DCC, EDC, and CDI, T3P® operates under mild conditions, minimizes racemization, and generates water-soluble byproducts that are easily removable. Its prominent application in amide and peptide coupling reactions has made it indispensable in medicinal chemistry and the synthesis of active pharmaceutical ingredients (APIs), delivering high yields with minimal epimerization in both solution- and solid-phase peptide synthesis. This review comprehensively covers T3P®-facilitated synthesis of diverse amides, including N-acyl tryptamines, N-acyl α-cyanoamines, cyanoaryl amides, N-acyl cyanoarylamines, o-ureidobenzonitriles, N-substituted amides, α-amino amides, N-acyl-benzotriazoles, dialkylamides, and N-formyl-imides. Beyond peptide chemistry, T3P® has proven effective for carboncarbon and carbon-heteroatom bond formation, as well as for condensation reactions via one-, two-, and three-component protocols. Representative transformations include the synthesis of αaminonitriles, 1-carbamatoalkyl 2-naphthols, and 3,4-dihydropyrimidin-2(1H)-ones/thiones via three-component reactions; isothiocyanates,β-enaminones, N-alkenylated heterocycles, β-amino ketones, N-(acyloxy)phthalimides, indole-based triarylmethanes, syn-diacetoxylated cinnamic esters, and aromatic aldehydes via two-component protocols; and nitriles via one-component protocols. By summarizing mechanistic insights, reaction scope, and emerging applications, this review underscores T3P® as a versatile, operationally simple, and environmentally conscious reagent for constructing structurally diverse and pharmaceutically relevant molecules in modern organic synthesis. In this paper, we provide an updated ten-year overview (2015-present), emphasizing T3P®'s versatility as a reagent in various bond-forming reactions.

Antimicrobial resistance represents one of the most formidable global health crises of the 21st century, driven by the diminishing efficacy of conventional antibiotics due to bacterial adaptation and biofilm formation. In response, antimicrobial nanoformulations have emerged as a transformative therapeutic paradigm, offering multifaceted and innovative mechanisms to combat resistant pathogens. This comprehensive review delineates the broad scope and distinct novelty of nano-enabled antimicrobial strategies, moving beyond the single-target limitations of traditional drugs. We systematically explore the diverse architectural classes of nanoformulations—including metallic, polymeric, and self-assembling nanostructures—and elucidate their unique mechanistic actions. These encompass (1) physical disruption of microbial membranes via electrostatic interactions; (2) catalytic generation of reactive oxygen and nitrogen species to induce an ‘oxidative storm’; (3) intracellular sabotage of essential metabolic pathways; (4) the ‘Trojan horse’ strategy for enhanced drug delivery and bioavailability; (5) efflux pump bypass to counteract a major resistance mechanism; (6) penetration and eradication of resilient biofilms; and (7) disarming pathogens through quorum sensing and virulence inhibition. Furthermore, this review highlights the immunomodulatory potential of nanoformulations; their activity beyond bacteria against fungi, viruses, and parasites; and the critical role of the nano-bio interface defined by surface physicochemistry. We also address the translational pathway, considering challenges in nanotoxicology, scalability, and regulatory approval, alongside the ecological impact and economic horizon of these technologies. This sector is projected to reach USD 5.4 to 8.96 billion by 2033 to 2034, with compound annual growth rates of 11 to 21% across antimicrobial nanomaterials, nanocoatings, and nanomedicine applications. By integrating insights from computational modeling and in silico design, this review underscores how nanoformulations leverage synergistic, multi-target approaches to overcome resistance, enhance therapeutic efficacy, and represent a significant leap forward in the future of infectious disease management. The novelty lies in the holistic and mechanistic synthesis of how nanotechnology is redefining antimicrobial warfare, offering a promising arsenal to avert a post-antibiotic era.

A brief summary of several kinds of heterocyclic rings (spiro, fused/bridged, and simple), which have been synthesized using significant approaches involving DBU as a catalyst, solvent, base, or reactant, is systematically provided.